Arkolith/Insider Trading/IMMX/Form 4

Hsu Jason

DirectorImmix Biopharma, Inc. (IMMX) · full profile →Form 4 · filed Dec 12, 2023
Net Buying
Open-Market Buys
$267K
Open-Market Sells
$0
Net Open-Market Flow
$267K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 11, 2023Buy(P)31K$4.67$145K813K
Dec 8, 2023Buy(P)25K$4.88$122K782K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-044618) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML